Skip to main content

Research Repository

Advanced Search

The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab

Rhodes, Anthony; Borthwick, Duncan; Sykes, Rob; Al-Sam, Salam; Paradiso, Angelo

Authors

Anthony Rhodes

Duncan Borthwick

Rob Sykes

Salam Al-Sam

Angelo Paradiso



Citation

Rhodes, A., Borthwick, D., Sykes, R., Al-Sam, S., & Paradiso, A. (2004). The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab. American Journal of Clinical Pathology, 122, 51-60. https://doi.org/10.1309/E9B5-5JYH-D84L-8Y17

Journal Article Type Article
Publication Date Jan 1, 2004
Journal American Journal of Clinical Pathology
Print ISSN 1943-7722
Publisher Oxford University Press (OUP)
Peer Reviewed Peer Reviewed
Volume 122
Pages 51-60
DOI https://doi.org/10.1309/E9B5-5JYH-D84L-8Y17
Keywords cell line standards, cancer centres, automated image analysis, HER-2, neu, cell line standards, immunohistochemical assays, image analysis
Public URL https://uwe-repository.worktribe.com/output/1062712
Publisher URL http://dx.doi.org/10.1309/E9B5-5JYH-D84L-8Y17




Downloadable Citations